The OPTIMAL Randomized Controlled Trial
NCT: NCT04111770 · COMPLETED
Brief Summary
The OPTIMAL study is a randomized, controlled, multicentre, international study. A total of 800 patients will be randomized in a 1:1 fashion to Intravascular Ultrasound (IVUS)-guided PCI versus qualitative angio(QCA)-guided Percutaneous Coronary Intervention (PCI). Patients will be consented prior to the PCI procedure and then followed up to 2 years after the index procedure for the last enrolled patient. Patients will be followed-up at 1 month (telephone contact), 12 months (outpatient clinic visit or telephone call) and yearly after (outpatient clinic visit or telephone call).
Frequently Asked Questions
What is The OPTIMAL Randomized Controlled Trial?
The OPTIMAL Randomized Controlled Trial is a clinical trial registered under NCT04111770. Current status: COMPLETED.
What is the status of NCT04111770?
The current status of NCT04111770 (The OPTIMAL Randomized Controlled Trial) is: COMPLETED.
When did The OPTIMAL Randomized Controlled Trial start?
The OPTIMAL Randomized Controlled Trial started on 2020-07-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.